Search results for "Psychosis"

showing 10 items of 324 documents

P-869 - „Two great masqueraders” in a psychiatry clinic - case series of neurosyphilis and neuroborreliosis

2012

Background Neurosyphilis can develop at any stage of syphilis despite of previously recieved treatment, and it can mimic any neuropschychiatric disorder. The psychopathology of neuroborreliosis is less described. Objectives To describe the cases of schizophrenia - like psychosis in patients with these hronic neuroinfections. Methods and materials Retrospective chart review study of five inmates (four with neurosyphilis and one with neuroborreliosis) was performed. Results Psychiatric histories of two females (45 and 49 y.o.) and three males (31, 40, 45 y.o.) are achieved. In four cases they were initially misdiagnosed as paranoid schizophrenia and in one case - as a persistent alcoholic hal…

medicine.medical_specialtyPsychosisParanoid schizophreniaPediatricsbusiness.industrymedicine.diseaseAlcoholic hallucinosisNeurosyphilisPsychiatry and Mental healthSchizophreniaMedicineSyphilisbusinessPsychiatryNeuroborreliosisPsychopathologyEuropean Psychiatry
researchProduct

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode ps…

2021

The work was supported by Guarantors of Brain post-doctoral clinical fellowship to DQ; Clinician Scientist Medical Research Council fellowship (project reference MR/M008436/1) to MDF; Heisenberg professorship from the German Research Founda- tion (grant no. 389624707) to UR; the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The EU-GEI Project is funded by the European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-…

medicine.medical_specialtyPsychosisPopulationNeurosciences. Biological psychiatry. NeuropsychiatryPHENOTYPESILLNESSPsychotic DisorderPredictive markersArticleCellular and Molecular NeuroscienceDEFICIT SYNDROMERisk FactorsFirst episode psychosismedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansCannabiClinical geneticsGenetic riskVALIDITYeducationSettore MED/25 - PsichiatriaSCHEDULEBiological PsychiatryMETAANALYSISCannabisUTILITYeducation.field_of_studyRisk FactorESQUIZOFRENIAASSOCIATIONCannabis usemedicine.diseaseBIFACTOR MODELPsychiatry and Mental healthPsychotic DisordersINTERRATER RELIABILITYSchizophreniaLinear ModelsSchizophreniaLinear ModelMedical geneticsPolygenic risk scorePsychologyHumanRC321-571Clinical psychology
researchProduct

Premorbid social adjustment is better in cannabis-using than non-using psychotic patients across Europe

2016

IntroductionA number of authors have hypothesized that psychotic patients who consume cannabis constitute a differentiated subgroup of patients that have better cognitive and social skills, necessary to engage in illegal drug consumption, than non-using patients.ObjectivesGiven that the prevalence, and patterns, of cannabis use are culturally driven, we wanted to study first-episode psychosis (FEP) cannabis-using and non-using patients coming from different European countries as part of the EUGEI-STUDY.AimsWe tested the hypothesis of better premorbid social adjustment in cannabis-using FEP patients, by comparing them to FEP non cannabis users and to their respective healthy controls.Methods…

medicine.medical_specialtyPsychosisSocial adjustmentbiologyPremorbid Adjustment Scalecannabis psychosis premorbid adjustmentCognitionbiology.organism_classificationmedicine.disease03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineSocial skillsmedicineIn patient030212 general & internal medicineCannabisPsychiatryPsychology030217 neurology & neurosurgeryRandom interceptClinical psychology
researchProduct

ReMindCare, an app for daily clinical practice in patients with first episode psychosis: A pragmatic real-world study protocol.

2021

[EN] Aim Despite the potential benefits of e-health interventions for patients with psychosis, the integration of these applications into the clinical workflow and analysis of their long-term effects still face significant challenges. To address these issues, we developed the ReMindCare app. This app aims to improve the treatment quality for patients with psychosis. We chose to study the app in real world and pragmatic manner to ensure results will be generalizable. Methods This is a naturalistic empirical study of patients in a first episode of psychosis programme. The app was purpose-designed based on two previous studies, and it offers the following assessments: (a) three daily questions…

medicine.medical_specialtyPsychosismedia_common.quotation_subjectPsychological interventionIrritabilitysmartphoneMedication Adherence03 medical and health sciences0302 clinical medicineEmpirical researchmental disordersmedicineCIENCIAS DE LA COMPUTACION E INTELIGENCIA ARTIFICIALElectronic Health RecordsHumansadherencepsychosisPsychiatryappBiological Psychiatrymedia_commonFirst episodeE-healthbusiness.industryEarly Intervention in the Real Worldmedicine.diseasePsychosisMental healthMobile Applications030227 psychiatrySadnessPsychiatry and Mental healthPsychotic DisordersAdherenceAnxietye‐healthSmartphonePshychiatric Mental Healthmedicine.symptombusinessApp030217 neurology & neurosurgeryEarly intervention in psychiatry
researchProduct

Mechanism of New Antipsychotic Medications

2003

Antagonism of D 2 -like dopamine receptors is the putative mechanism underlying the antipsychotic efficacy of psychotropic drugs. Positron emission tomographic studies suggest that the antipsychotic effect of dopamine receptor antagonists occurs within a therapeutic window between 60% and 80%(striatal) D 2 receptor occupancy. The incidence of extrapyramidal side effects increases above the 80% threshold. However, the novel atypical antipsychotic drug, aripiprazole, occupies up to 95% of striatal D 2 -like dopamine receptors at clinical doses, and the incidence of extrapyramidal side effects with aripiprazole is no higher than with placebo. The most likely explanation for this finding is ari…

medicine.medical_specialtyPsychosismedicine.drug_classmedicine.medical_treatmentAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistPiperazinesBasal Ganglia DiseasesArts and Humanities (miscellaneous)Dopamine receptor D2Internal medicinemedicineHumansAntipsychoticDose-Response Relationship DrugReceptors Dopamine D2Putamenmedicine.diseaseCorpus StriatumProlactinDopamine D2 Receptor AntagonistsPsychiatry and Mental healthEndocrinologyMechanism of actionDopamine receptorSchizophreniaAripiprazolemedicine.symptomPsychologyAntipsychotic AgentsTomography Emission-Computedmedicine.drugArchives of General Psychiatry
researchProduct

Psychosis, Need Adapted treatment, and psychiatrists' agency

2013

Background: In the Need-Adapted approach (NAA) therapy meetings are a deliberate effort to bring all meaningful parties and views to a common discussion prior to decisions; this constitutes a challenge for psychiatrists’ agency. Aims: To describe how psychiatrists see their agency in NAA. Methods: Using videos of co-research interviews, stimulated-recall interviews of 10 interviewees were conducted and transcribed verbatim. The material was analyzed via an adapted dialogical-narrative analytical method. Results: Institutional forces were experienced as having an enormous impact on psychiatrists’ agency, especially in the inpatient setting, reducing professional creativity. In the outpatient…

medicine.medical_specialtyPsychosissisäinen dialogilääkärin toimijuusmedia_common.quotation_subjectbehavioral disciplines and activitiesinner dialoguepsychiatrists’ agencyAgency (sociology)mental disordersOutpatient settingmedicinepsychosisPsychiatryta515media_commonNeed-Adapted treatmentMedical educationTarpeenmukainen hoitoDialogical selfpsykoosiInpatient settingCreativitymedicine.diseaseHospital carePsychiatry and Mental healthPsychologyPsychosis: Psychological, Social and Integrative Approaches
researchProduct

Dreaming and the neurobiology of self: recent advances and implications for psychiatry

2013

Throughout most of the 20th century, dreaming was considered at the center of the leading psychotherapeutic approaches to mental disorders. Psychodynamic models of the mind stemmed from Sigmund Freud's Interpretation of Dreams, according to which knowledge of the unconscious foundations of most symptoms could be enhanced by an accurate evaluation of reported dreams. Toward the end of the century, these conceptualizations were challenged by a progressive shift of perspective in the direction of neurobiologically informed, mechanistic models of brain dysfunction. The diffusion of effective psychotropic medications developed to target specific symptoms across different disorders contributed to…

medicine.medical_specialtyUnconscious mindsense of agencymedia_common.quotation_subjectlcsh:BF1-990lucidityPsychological TechniquesmedicinePsychologydreamingpsychosisDreamPsychiatryContent (Freudian dream analysis)General Psychologymedia_commonself-monitoringCognitionOpinion Articlemedicine.diseasePsychodynamicsminimal selfschizophrenialcsh:Psychologycorollary dischargeSchizophreniaConsciousnessPsychologyNeuroscienceFrontiers in Psychology
researchProduct

Working Memory, Jumping to Conclusions and Emotion Recognition: a Possible Link in First Episode Psychosis (Fep)

2015

Introduction A large body of literature has demonstrated that people affected by psychotic disorders show deficits in working memory, in Emotion Recognition (ER) and in data-gathering to reach a decision (Jumping To Conclusions – JTC). Aims To investigate a possible correlation between working memory, JTC and ER in FEP. Methods 41 patients and 89 healthy controls completed assessments of working memory using WAIS shortened version, JTC using the 60:40 Beads Task and ER using Degraded Facial Affect Recognition Task. Results According to the literature, cases had poorer performance in working memory tasks (Digit Span: μ7,72 [ds=2,98] vs μ10,14 [ds=3,10], U=865,00, p=0,00; Digit Symbol: μ5,36 …

medicine.medical_specialtyWorking memoryWechsler Adult Intelligence ScaleAudiologyworking memory psychosis emotionDevelopmental psychologyCorrelationPsychiatry and Mental healthSettore M-PSI/08 - Psicologia ClinicaFirst episode psychosisJumping to conclusionsSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineMemory spanEmotion recognitionPsychologySettore MED/25 - PsichiatriaEarly rehabilitationEuropean Psychiatry
researchProduct

The independent and combined influence of schizophrenia polygenic risk score and heavy cannabis use on risk for psychotic disorder: A case-control an…

2019

Background: Some recent studies have challenged the direction of causality for the association between cannabis use and psychotic disorder, suggesting that cannabis use initiation is explained by common genetic variants associated with risk of schizophrenia. We used data from the European Union Gene-Environment Interaction consortium (EUGEI) case-control study to test for the independent and combined effect of heavy cannabis use, and of Schizophrenia Polygenic risk score (SZ PRS), on risk for psychotic disorder. Methods: Genome-wide data were obtained from 492 first episode psychosis patients (FEPp) and from 787 controls of European Ancestry, and used to generate SZ PRS from the summary res…

medicine.medical_specialtybiologybusiness.industryFrequency of useCannabis usebiology.organism_classificationmedicine.disease030227 psychiatry3. Good health03 medical and health sciences0302 clinical medicineSchizophreniaFirst episode psychosisCase control analysisMedicinemedia_common.cataloged_instancePolygenic risk scoreCannabisEuropean unionbusinessPsychiatry030217 neurology & neurosurgerymedia_common
researchProduct

O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CON…

2019

Background FEP patients who use cannabis experience more frequent intoxication experiences compared to controls. It is not clear whether this is consequent to patients being more vulnerable to the effects of cannabis use or to their heavier pattern of use. We aimed to determine whether extent of use predicted psychotic-like and euphoric intoxication experiences in FEP patients and controls and whether this differs between groups. Methods We analysed data on lifetime cannabis using patients (n=655) and controls (n=654) across 15 sites from six countries in the EU-GEI study (2010–2015). We used multiple regression to model predictors of cannabis-induced experiences and Factorial ANOVA to dete…

medicine.medical_specialtybusiness.industryAcute intoxicationSample (statistics)Cannabis usePsychiatry and Mental healthMulti nationalOral Abstractspsychosis cannabis psychotic-like experiences intoxicationFirst episode psychosisMedicineAssociation (psychology)businessPsychiatrySettore MED/25 - PsichiatriaSchizophrenia Bulletin
researchProduct